Isovx 20 Softgel Capsule contains isotretinoin 10mg, a retinoid derivative primarily indicated for the treatment of severe recalcitrant nodular acne that is unresponsive to conventional therapies such as antibiotics and topical agents. Isotretinoin acts by reducing sebaceous gland size and sebum production, inhibiting comedogenesis, and exerting anti-inflammatory effects, thereby addressing multiple pathogenic factors of acne. The softgel formulation facilitates improved bioavailability and ease of administration. Isovx 20 should be prescribed with caution due to its well-documented teratogenic potential; strict adherence to pregnancy prevention programs is mandatory for female patients of childbearing potential. Common adverse effects include dryness of skin and mucous membranes, cheilitis, and transient elevations in liver enzymes and lipid profiles, necessitating regular monitoring during therapy. Patients should be advised to avoid excessive sun exposure and use appropriate skin moisturizers. Isovx 20 is contraindicated in pregnancy, lactation, and patients with hypersensitivity to isotretinoin or any component of the formulation. Liver function tests, lipid profiles, and complete blood counts should be assessed prior to initiation and periodically throughout the treatment course. This medication should be used under close medical supervision to optimize therapeutic outcomes and minimize potential risks.